Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
Tilray Brands Inc. (TLRY) maintains a dynamic presence in global cannabis markets through its medical research initiatives and consumer product innovations. This resource provides investors and industry observers with centralized access to verified corporate announcements, regulatory developments, and market analysis.
Users will find updates spanning earnings reports, international expansion efforts, and product portfolio enhancements, including developments in cannabis-infused wellness solutions. The curated selection enables stakeholders to track operational milestones across Tilray's pharmaceutical-grade production facilities and lifestyle brand divisions.
All content undergoes strict verification to ensure alignment with financial disclosure standards and industry regulations. Regular updates reflect Tilray's position as a GMP-certified producer serving medical markets in 20+ countries while expanding recreational offerings in emerging markets.
Bookmark this page for streamlined monitoring of Tilray's strategic initiatives, quality control advancements, and responses to evolving cannabis legislation worldwide.
Tilray Brands has received approval from the Italian Ministry of Health to import and distribute its medical cannabis oral solution THC25 through its division, FL Group. This approval signifies a critical expansion into the Italian market, where it's expected to enhance patient access to medical cannabis. Tilray Medical operates in 22 countries and is known for its EU-GMP certified products. The company emphasizes its commitment to quality and responsible cannabis regulations, aiming to meet patient needs effectively.
Tilray Brands announces the launch of RIFF Drumsticks, a new range of premium infused pre-rolls, available across Ontario. Released on September 15, 2022, these limited-edition products are made with Granddaddy Purp whole flower, offering enhanced THC potency and fruity aromas. The unique pre-rolls are rolled in unbleached paper, dipped in distillate, and coated in kief for an elevated experience. The RIFF brand aims to connect with cannabis consumers seeking flavorful and potent products.
Tilray Brands, Inc. announced the renewal and expansion of Breckenridge Distillery's distribution agreement with Republic National Distributing Company (RNDC). This agreement allows for direct access to RNDC’s extensive network covering 38 states and the District of Columbia. Breckenridge Distillery, known for its award-winning spirits, including bourbon whiskey, aims to accelerate brand growth through this partnership. Breckenridge’s products have received numerous accolades, enhancing the distillery's profile and market reach.
Tilray Brands (Nasdaq: TLRY) has initiated a policy roundtable with German regulators to discuss adult-use cannabis legalization. The meeting featured German Drug Commissioner Burkhard Blienert, who announced a draft bill for legalization expected soon. Tilray aims to leverage its expertise to support this legislation, emphasizing product quality and safety. The company has a strong history in the cannabis sector, being the first to export medical cannabis from North America to the EU. Tilray's operations in Germany include EU-GMP certified production facilities.
Tilray Brands (Nasdaq: TLRY) has announced the expansion of its Good Supply cannabis portfolio, introducing new high-potency concentrates: Jean Guy Badder, Pineapple Express Hash Bats, and Orange Frost Live Resin. These products highlight the brand's commitment to quality and consumer experience, offering enhanced potency and flavor. Additionally, the launch of two new strains, Monkey Butter and Sweet Berry Kush, is set to reach new sizes and provinces, following strong demand. Good Supply remains a prominent brand in Canada’s cannabis market.
Tilray Brands has expanded its medical cannabis portfolio in Canada with new products under the Tilray and Aphria brands. Notably, it introduced CannaPoints, a program designed to support patients in their medical cannabis journey. The product line includes high-THC strains such as Tilray Sinaloa Gold and Aphria Sherbet Cookies, catering to diverse patient needs. Additionally, Tilray Medical partnered with Strainprint to enhance patient experience through the CannaPoints program, which guides users in exploring cannabis products and tracking their effects.
Tilray Medical, a division of Tilray Brands (Nasdaq: TLRY), has received approval from the Natural Health Science Foundation (NHSF) for its CBD100 product to be utilized in clinical trials in Australia and New Zealand. This verification highlights Tilray’s commitment to quality and safety in medical cannabis. The NHSF approval confirms that Tilray Purified Oral Solution meets rigorous standards for reproducibility and scientific validity. Additionally, the New Zealand Ministry of Health has verified product quality, further establishing Tilray Medical as a trusted provider in the region.
Tilray Brands has received approval from the Polish Ministry of Health to distribute its Tilray branded medical cannabis products in Poland, enhancing its European market presence.
Tilray Medical, which operates in 21 countries, focuses on providing high-quality THC and CBD products to patients. The company has established partnerships with local pharmaceutical companies to facilitate pharmacy distribution, allowing patients to obtain prescriptions through their doctors.
Tilray continues to advocate for patient access to reliable medical cannabis across Europe.
Breckenridge Distillery has announced the release of two limited-edition Mile High Bourbon Blends, launching on August 8, 2022. This collaboration with the Denver Broncos features alumni Jake Plummer and Karl Mecklenburg blending bourbons that encapsulate unique flavor profiles. The blends, encased in commemorative bottles, celebrate the Broncos' legacy. The first blend received accolades, including Best American Blended Whiskey. Breckenridge Distillery, known for its award-winning spirits, was acquired by Tilray Brands, Inc. in December 2021.
Tilray Brands has announced a strategic distribution agreement with Southern Glazer's Wine & Spirits for its Tilray Wellness division. This deal grants access to Southern Glazer's extensive distribution network, reaching various retail channels across 13 states, paving the way for Tilray's entry into the booming CBD beverage market. Jared Simon, President of Tilray Wellness, noted that this partnership positions the company for significant growth in the multi-billion-dollar adult beverage sector with a non-alcoholic CBD alternative.
FAQ
What is the current stock price of TILRAY BRANDS (TLRY)?
What is the market cap of TILRAY BRANDS (TLRY)?
